March 22, 2025 - 17:44

MARIETTA — Memorial Health System’s Department of Cardiology recently celebrated a significant achievement in advanced cardiac care by completing its 100th transcatheter aortic valve replacement (TAVR) procedure. This milestone was reached under the expertise of Interventional Cardiologist Jason Schott, DO, and Cardiothoracic Surgeon Geoffrey R. Cousins, MD, FACS.
As the only health system in the region providing TAVR, Memorial Health System has established itself as a leader in innovative heart treatments. The TAVR procedure offers a less invasive option for patients suffering from aortic valve stenosis, allowing for quicker recovery times compared to traditional open-heart surgery.
The success of the program reflects the dedicated efforts of the entire cardiology team, who are committed to improving patient outcomes and enhancing the quality of care. With this achievement, Memorial Health System continues to pave the way for advanced cardiac solutions, ensuring that patients receive the best possible treatment close to home.
July 30, 2026 - 02:45
Texas health issues alert after 4 Montgomery County residents infected with measlesTexas health authorities have issued a public health alert after four members of an unvaccinated family in Montgomery County tested positive for measles. The cases, all linked to a single household...
July 29, 2026 - 08:53
Local nonprofits call for changes at Bexar County jail over custody deaths, healthcare concernsHouston, Dallas, and San Antonio operate the three largest county jail systems in Texas. But so far this year, Bexar County has recorded the highest number of deaths among inmates in custody,...
July 28, 2026 - 17:12
Private Equity Firm Unloads Mental Health Chain Into Muni MarketA private equity firm based in Connecticut is moving to offload a network of mental health clinics and sober-living facilities, using a financing structure that taps into the municipal bond market....
July 28, 2026 - 03:52
Peptides are the latest wellness trend – but do they work?A US drug advisory committee has recently given a nod of approval to several experimental peptides, signaling a potential shift in how these compounds are viewed by regulators. Yet despite the...